Sildenafil for women patients with antidepressant-induced sexual dysfunction

Some women taking Viagra may find that having sex is more pleasurable.

Rights and permissions

While it may improve physical arousal for some, Viagra doesn’t directly impact desire. If you’re struggling with low libido, you’re not alone, and real help is available. Sign up for our Health Essentials emails for expert guidance on nutrition, fitness, sleep, skin care and more. The steroid medication may raise your blood pressure and cause heart palpitations Lower your risk by sticking to the right dose and avoiding long-term use without medical guidance Authorized take-back programs, services and drop-off locations are the best, safest way to get rid of expired medicine These illegal supplements have negative impacts for vital organs and may cause psychosis, heart attacks and more Popular among teens, these inhalants give you a quick high, with serious harmful effects ‘Black box warnings’ on medications outline potential risks and important instructions These similar versions of brand-name drugs are safe, effective and often less expensive Though these painkillers work in different ways, they can both help reduce a fever and pain These tiny saltwater larvae can get trapped under your swimsuit and trigger an itchy reaction called seabather’s eruption Searching nature for edible items requires training and knowledge to avoid poisonous plants Yes, but you can protect yourself with hats, scarves or even hair sunblock Aging WellAllergiesCancer Care & PreventionChronic PainCold, Flu & Respiratory IllnessesDiabetes & EndocrinologyDigestiveEar, Nose & ThroatEye CareInfectious DiseaseLungOral HealthParentingPregnancy & ChildbirthRecipesRheumatology & ImmunologySenior HealthSex & RelationshipsSleepUrinary & Kidney HealthWeight Loss Rendered: Mon May 25 2026 22:05:31 GMT+0000 (Coordinated Universal Time) Treatment-emergent sexual dysfunction is a frequent adverse effect occurring with medication use and is a major influence for premature discontinuation of antidepressant treatment, which leads to treatment failure and costly disease management outcomes. Sexual dysfunction is recognized as being associated with selective and nonselective serotonin reuptake inhibitor (SRI) antidepressants, which are the most frequently prescribed medications for outpatients aged 18 to 65 years and represent 90% of the 180 million antidepressant prescriptions filled in the United States.1 Antidepressant treatment–associated sexual dysfunction is estimated to occur in 30% to 70% of men and women treated for major depression with first- or second-generation agents,2 a principal reason for a 3-fold increased risk of nonadherence that approaches 70% in the first months of treatment and leads to increased relapse, recurrence, disability, and resource utilization by affected patients.3 However, the literature in this field is less developed for women with more highly variable prevalence rates and less conclusive data compared with men.

Professional resources

In women, sexual dysfunction is associated with decreased sexual interest, genital sensitivity, and vaginal lubrication; delayed or absent orgasm; dyspareunia; reduced sexual activity; and overall dissatisfaction or loss of pleasure in sexual relations. Among the numerous strategies proposed for managing sexual dysfunction associated with SRI treatment, selective phosphodiesterase type 5 inhibitors, which have been limited to studies involving men, have demonstrated the best evidence-based data to support broad-based and clinically meaningful treatment efficacy.4 However, to our knowledge, no randomized controlled trial (RCT) has demonstrated effectiveness for women experiencing sexual dysfunction associated with SRI treatment. Compared with men, women are prescribed antidepressants at rates of 2 to 1 and can be expected to represent a significant number of patients needing relief.5 Without evidence-based data to treat sexual function associated with SRIs in women, clinicians may lack the confidence to manage it effectively, which leaves patients exposed to excess random pharmacology.6 Although sexual dysfunction is a major influence in determining the selection or switching of antidepressants, it is frequently overlooked because clinicians fail to inquire, misattribute it as a symptom of depression that will improve with treatment, or because 80% of women do not discuss adverse sexual effects with their physician.7,8 Sexual dysfunction associated with SRIs is dose related, usually occurs early in treatment, and rarely remits spontaneously. Selective phosphodiesterase type 5 inhibitors (sildenafil, vardenafil, tadalafil), which are effective and well tolerated for treatment of erectile dysfunction in men,9 including men with depression10 and associated with SRI treatment,11 are not approved by the US Food and Drug Administration (FDA) for women with sexual dysfunction. However, interest in their potential use in women was encouraged by reports that nitric oxide synthase isoforms, nitric oxide, and phosphodiesterase type 5 inhibitors are present in female genital tissue, and phosphodiesterase type 5 inhibitor enhancement of nitric oxide–cyclic guanosine monophosphate in nonadrenergic-noncholinergic signaling for women seems similar to men.12 When several trials involving premenopausal and postmenopausal women treated with sildenafil failed to demonstrate significant improvements for sexual arousal disorder,13 the manufacturer abandoned pursuit of FDA approval for treating women.

Competing interests

Subsequent RCTs narrowed their focus on more specific hormonal factors and demonstrated efficacy with improved frequency of sexual intercourse, arousal, orgasm, and satisfaction. One trial involved premenopausal women with sexual arousal disorder but with normal sexual desire. They were randomized to receive 1 of 3 treatments: 25 mg or 50 mg of sildenafil or placebo.14 A protocol-specified trial involved premenopausal or postmenopausal women with sexual arousal disorder without concomitant hypoactive sexual desire disorder. Women with low baseline estrogen and androgen levels received therapy, so their hormone levels would be within the range of normal therapy and were randomly assigned to receive either a flexible dose of between 25 mg and 100 mg of sildenafil or placebo.15 In a third trial, postmenopausal women receiving estrogen hormone therapy and who had acquired sexual arousal disorder and impaired orgasm found that a single dose of 50 mg of sildenafil compared with placebo reduced orgasm latency and increased subjective arousal in those having the lowest vaginal pulse amplitude percentage change.16 In a fourth trial involving asymptomatic premenopausal women, a sildenafil-placebo crossover reported increased arousal and orgasm function.17 Case reports18 and open-label studies19 have also suggested efficacy for phosphodiesterase type 5 inhibitor treatment of women with sexual dysfunction associated with SRI treatment. The objective of our current trial was to use a protocol—similar to our previous RCT11 involving men with sexual dysfunction associated with SRI treatment—to assess the efficacy of sildenafil in the treatment of women, specifically women whose major depressive order is in remission while taking a stable dose of SRI antidepressants and who did not have a preexisting sexual dysfunction but due to the treatment had sexual dysfunction manifest as dysfunction of orgasm (delay) or arousal (lubrication).5 Recognizing the importance of the hormonal variability on nitric oxide signaling in sexual function in women20 and depression on hypothalamic-pituitary–adrenal axis regulation,21 we also examined endocrine measures. (And who can argue with that as a perk?) But that’s not true for everyone. Some women taking Viagra may experience side effects like: If you have low blood pressure or you’re taking blood pressure medication, Viagra can cause a further drop that may lead to dizziness and even fainting.

Product	Dosage	Quantity + Bonus	Price
Kamagra Polo	100mg	60 + 4 Pills	189.39€ 180.37€	Buy
Kamagra Oral Jelly	100mg	21 Sachets	95.92€ 91.35€	Buy
Viagra Generic	50mg	20 Pills	40.52€ 38.59€	Buy
Kamagra Oral Jelly	100mg	220 + 18 Sachets	662.24€ 630.70€	Buy
Kamagra Oral Jelly	100mg	63 + 7 Sachets	224.18€ 213.50€	Buy
Viagra Generic	50mg	180 + 8 Pills	158.82€ 151.26€	Buy
Viagra Generic	100mg	180 + 8 Pills	199.37€ 189.88€	Buy
Kamagra Soft Tabs	100mg	180 + 8 Pills	425.45€ 405.19€	Buy
Kamagra Soft Tabs	100mg	84 + 4 Pills	233.05€ 221.95€	Buy
Kamagra Oral Jelly	100mg	90 + 8 Sachets	303.56€ 289.10€	Buy
Viagra Generic	50mg	90 + 6 Pills	107.37€ 102.26€	Buy
Viagra Generic	200mg	360 + 10 Pills	481.98€ 459.03€	Buy
Kamagra Polo	100mg	84 + 4 Pills	244.49€ 232.85€	Buy
Kamagra Oral Jelly	100mg	10 Sachets	54.55€ 51.95€	Buy
Kamagra Polo	100mg	20 Pills	83.56€ 79.58€	Buy
Viagra Generic	25mg	10 Pills	25.19€ 23.99€	Buy

And mixing Viagra and alcohol is a big no-no because it can worsen the side effects, Dr. Zanotti warns.

Precaution	Rationale	Advice
Medical consultation	To rule out contraindications	Always consult prior to use
Avoid Nitrates	Risk of severe hypotension in combination	Do not combine with nitrates
Monitoring Blood Pressure	Possible hypotensive effects	Check BP regularly
Use under medical supervision	For dosage and safety guidance	Essential for off-label use

While Viagra might work on the physical side of things, other FDA-approved treatments can help women with other issues, like sexual desire. “Viagra might help some women with the physical mechanics of sex, but it’s not going to help with other things that keep you from being ‘in the mood,’” Dr. Zanotti points out. No pill is going to make sure the laundry is done, the kids are asleep, or that you’re feeling confident in yourself and your relationship.

• Future studies may clarify sildenafil’s effectiveness for women.
• Regulatory approval for women may be granted if proven safe.
• Personalized medicine approaches could enhance treatment outcomes.
• In the meantime, women should seek professional advice before use.

But Dr. Zanotti notes a few medications that may help increase your interest in sex: Addyi® (flibanserin): A daily pill for premenopausal women with low sexual desire. It affects brain chemicals tied to libido. Like Viagra, it can lower blood pressure and shouldn’t be taken with alcohol.

Statistical Analysis

Vyleesi® (bremelanotide): sildenafil citrate sublingual tablets 100mg A self-injection that you use before sex. It’s approved only for premenopausal women whose low libido isn’t caused by another health condition.

Frequently asked questions

Some women taking Viagra may find that having sex is more pleasurable. (And who can argue with that as a perk?) But that’s not true for everyone. Some women taking Viagra may experience side effects like: If you have low blood pressure or you’re taking blood pressure medication, Viagra can cause a further drop that may lead to dizziness and even fainting. And mixing Viagra and alcohol is a big no-no because it can worsen the side effects, Dr. Zanotti warns.

Full Text Sources

While Viagra might work on the physical side of things, other FDA-approved treatments can help women with other issues, like sexual desire. “Viagra might help some women with the physical mechanics of sex, but it’s not going to help with other things that keep you from being ‘in the mood,’” Dr. Zanotti points out. No pill is going to make sure the laundry is done, the kids are asleep, or that you’re feeling confident in yourself and your relationship. But Dr.

Future Directions

Zanotti notes a few medications that may help increase your interest in sex: Addyi® (flibanserin): A daily pill for premenopausal women with low sexual desire. It affects brain chemicals tied to libido. Like Viagra, it can lower blood pressure and shouldn’t be taken with alcohol. Vyleesi® (bremelanotide): sildenafil citrate sublingual tablets 100mg A self-injection that you use before sex. It’s approved only for premenopausal women whose low libido isn’t caused by another health condition. Wellbutrin® (bupropion): An antidepressant that may help improve libido, especially if your low sex drive is related to depression or SSRI use. Hormone replacement therapy (HRT): This may help improve vaginal dryness and restore sexual comfort (thus, boosting libido) for women going through menopause. Testosterone therapy: This can be prescribed to treat low libido in women entering menopause and in the years that follow. Sometimes, sexual dysfunction isn’t about biology — it’s about everything else going on in your life that puts sex on the back burner. “Sexual health in women is about more than just blood flow,” Dr.

Similar questions

Premenopausal women affected by sexual arousal disorder treated with sildenafil: a double-blind, cross-over, placebo-controlled study

Zanotti says. “It’s about your mental health, your relationship, how comfortable you feel in your body and so much more.” Here are a few strategies that may help: If sex is painful, pelvic floor physical therapy may help. As you get older, vaginal tissue becomes drier and less elastic. Using lubricants or vaginal moisturizers, particularly after menopause, can help can make sex more pleasurable.

• Some studies investigate sildenafil’s impact on vaginal blood flow.
• Psychological factors also significantly influence female sexual response.
• Not all women will experience improved sexual function with sildenafil.
• Sexual therapy remains an important treatment option.

Prioritize exercise, manage stress and sleep — they can all affect your sex drive more than you might think. Talk with a therapist, especially one who specializes in sexual health or trauma, if your low sex drive is related to things like mental health concerns, past sexual trauma or negative body image. Have an open conversation with your healthcare provider. They can help you identify the cause and explore personalized solutions. Viagra might sildenafil pink pill sound like a quick fix, but it rarely is. Because the research hasn’t proven that it’s beneficial for women, most healthcare providers consider it a last resort — not a first-line treatment.

Country	Status	Notes
USA	Off-label, experimental use	Not FDA approved for women
UK	Similar to US, off-label	Prescription only
Australia	Not approved for women	Research under consideration
Canada	Experimental use in clinical trials	Not commercially available

While it may improve physical arousal for some, Viagra doesn’t directly impact desire. If you’re struggling with low libido, you’re not alone, and real help is available. Sign up for our Health Essentials emails for expert guidance on nutrition, fitness, sleep, skin care and more.

Access through your organization

The steroid medication may raise your blood pressure and cause heart palpitations Lower your risk by sticking to the right dose and avoiding long-term use without medical guidance Authorized take-back programs, services and drop-off locations are the best, safest way to get rid of expired medicine These illegal supplements have negative impacts for vital organs and may cause psychosis, heart attacks and more Popular among teens, these inhalants give you a quick high, with serious harmful effects ‘Black box warnings’ on medications outline potential risks and important instructions These similar versions of brand-name drugs are safe, effective and often less expensive Though these painkillers work in different ways, they can both help reduce a fever and pain These tiny saltwater larvae can get trapped under your swimsuit and trigger an itchy reaction called seabather’s eruption Searching nature for edible items requires training and knowledge to avoid poisonous plants Yes, but you can protect yourself with hats, scarves or even hair sunblock Aging WellAllergiesCancer Care & PreventionChronic PainCold, Flu & Respiratory IllnessesDiabetes & EndocrinologyDigestiveEar, Nose & ThroatEye CareInfectious DiseaseLungOral HealthParentingPregnancy & ChildbirthRecipesRheumatology & ImmunologySenior HealthSex & RelationshipsSleepUrinary & Kidney HealthWeight Loss Rendered: Mon May 25 2026 22:05:31 GMT+0000 (Coordinated Universal Time) Treatment-emergent sexual dysfunction is a frequent adverse effect occurring with medication use and is a major influence for premature discontinuation of antidepressant treatment, which leads to treatment failure and costly disease management outcomes. Sexual dysfunction is recognized as being associated with selective and nonselective serotonin reuptake inhibitor (SRI) antidepressants, which are the most frequently prescribed medications for outpatients aged 18 to 65 years and represent 90% of the 180 million antidepressant prescriptions filled in the United States.1 Antidepressant treatment–associated sexual dysfunction is estimated to occur in 30% to 70% of men and women treated for major depression with first- or second-generation agents,2 a principal reason for a 3-fold increased risk of nonadherence that approaches 70% in the first months of treatment and leads to increased relapse, recurrence, disability, and resource utilization by affected patients.3 However, the literature in this field is less developed for women with more highly variable prevalence rates and less conclusive data compared with men. In women, sexual dysfunction is associated with decreased sexual interest, genital sensitivity, and vaginal lubrication; delayed or absent orgasm; dyspareunia; reduced sexual activity; and overall dissatisfaction or loss of pleasure in sexual relations. Among the numerous strategies proposed for managing sexual dysfunction associated with SRI treatment, selective phosphodiesterase type 5 inhibitors, which have been limited to studies involving men, have demonstrated the best evidence-based data to support broad-based and clinically meaningful treatment efficacy.4 However, to our knowledge, no randomized controlled trial (RCT) has demonstrated effectiveness for women experiencing sexual dysfunction associated with SRI treatment. Compared with men, women are prescribed antidepressants at rates of 2 to 1 and can be expected to represent a significant number of patients needing relief.5 Without evidence-based data to treat sexual function associated with SRIs in women, clinicians may lack the confidence to manage it effectively, which leaves patients exposed to excess random pharmacology.6 Although sexual dysfunction is a major influence in determining the selection or switching of antidepressants, it is frequently overlooked because clinicians fail to inquire, misattribute it as a symptom of depression that will improve with treatment, or because 80% of women do not discuss adverse sexual effects with their physician.7,8 Sexual dysfunction associated with SRIs is dose related, usually occurs early in treatment, and rarely remits spontaneously.

• Sildenafil is being studied for female sexual dysfunction.
• It may improve blood flow to vaginal tissues.
• Not officially approved for women in many countries.
• Side effects can include headaches and flushing.

Selective phosphodiesterase type 5 inhibitors (sildenafil, vardenafil, tadalafil), which are effective and well tolerated for treatment of erectile dysfunction in men,9 including men with depression10 and associated with SRI treatment,11 are not approved by the US Food and Drug Administration (FDA) for women with sexual dysfunction. However, interest in their potential use in women was encouraged by reports that nitric oxide synthase isoforms, nitric oxide, and phosphodiesterase type 5 inhibitors are present in female genital tissue, and phosphodiesterase type 5 inhibitor enhancement of nitric oxide–cyclic guanosine monophosphate in nonadrenergic-noncholinergic signaling for women seems similar to men.12 When several trials involving premenopausal and postmenopausal women treated with sildenafil failed to demonstrate significant improvements for sexual arousal disorder,13 the manufacturer abandoned pursuit of FDA approval for treating women. Subsequent RCTs narrowed their focus on more specific hormonal factors and demonstrated efficacy with improved frequency of sexual intercourse, arousal, orgasm, and satisfaction. One trial involved premenopausal women with sexual arousal disorder but with normal sexual desire. They were randomized to receive 1 of 3 treatments: 25 mg or 50 mg of sildenafil or placebo.14 A protocol-specified trial involved premenopausal or postmenopausal women with sexual arousal disorder without concomitant hypoactive sexual desire disorder. Women with low baseline estrogen and androgen levels received therapy, so their hormone levels would be within the range of normal therapy and were randomly assigned to receive either a flexible dose of between 25 mg and 100 mg of sildenafil or placebo.15 In a third trial, postmenopausal women receiving estrogen hormone therapy and who had acquired sexual arousal disorder and impaired orgasm found that a single dose of 50 mg of sildenafil compared with placebo reduced orgasm latency and increased subjective arousal in those having the lowest vaginal pulse amplitude percentage change.16 In a fourth trial involving asymptomatic premenopausal women, a sildenafil-placebo crossover reported increased arousal and orgasm function.17 Case reports18 and open-label studies19 have also suggested efficacy for phosphodiesterase type 5 inhibitor treatment of women with sexual dysfunction associated with SRI treatment.

Other FDA‑approved treatments for low libido in women

Wellbutrin® (bupropion): An antidepressant that may help improve libido, especially if your low sex drive is related to depression or SSRI use. Hormone replacement therapy (HRT): This may help improve vaginal dryness and restore sexual comfort (thus, boosting libido) for women going through menopause. Testosterone therapy: This can be prescribed to treat low libido in women entering menopause and in the years that follow. Sometimes, sexual dysfunction isn’t about biology — it’s about everything else going on in your life that puts sex on the back burner. “Sexual health in women is about more than just blood flow,” Dr.

Addyi (filbanserin)

Zanotti says. “It’s about your mental health, your relationship, how comfortable you feel in your body and so much more.” Here are a few strategies that may help: If sex is painful, pelvic floor physical therapy may help. As you get older, vaginal tissue becomes drier and less elastic. Using lubricants or vaginal moisturizers, particularly after menopause, can help can make sex more pleasurable. Prioritize exercise, manage stress and sleep — they can all affect your sex drive more than you might think.

Biochemical Factors Modulating Female Genital Sexual Arousal Physiology

Talk with a therapist, especially one who specializes in sexual health or trauma, if your low sex drive is related to things like mental health concerns, past sexual trauma or negative body image. Have an open conversation with your healthcare provider. They can help you identify the cause and explore personalized solutions. Viagra might sildenafil pink pill sound like a quick fix, but it rarely is. Because the research hasn’t proven that it’s beneficial for women, most healthcare providers consider it a last resort — not a first-line treatment. The objective of our current trial was to use a protocol—similar to our previous RCT11 involving men with sexual dysfunction associated with SRI treatment—to assess the efficacy of sildenafil in the treatment of women, specifically women whose major depressive order is in remission while taking a stable dose of SRI antidepressants and who did not have a preexisting sexual dysfunction but due to the treatment had sexual dysfunction manifest as dysfunction of orgasm (delay) or arousal (lubrication).5 Recognizing the importance of the hormonal variability on nitric oxide signaling in sexual function in women20 and depression on hypothalamic-pituitary–adrenal axis regulation,21 we also examined endocrine measures.